Greece - Sold Production of Medicaments, Containing Alkaloids or Derivatives Thereof, But Not Hormones or Antibiotics

Since 2014, Greece Sold Production of Medicaments, Containing Alkaloids or Derivatives Thereof, But Not Hormones or Antibiotics rose 0.7% year on year. At €870,508,456.38 in 2019, the country was number 13 comparing other countries in Sold Production of Medicaments, Containing Alkaloids or Derivatives Thereof, But Not Hormones or Antibiotics. Greece is overtaken by Netherlands, which was number 12 at €935,716,741.45 and is followed by Sweden at €641,811,971.12. Germany topped the ranking with €16,376,860,638.2 in 2019, that is a growth of 0.5% versus 2018. Ireland, France and United Kingdom respectively ranked number 2, 3 and 4 in this ranking. Sweden witnessed the best average annual growth at +62.7% per year, while Montenegro recorded the worst performance at -6.3% per year.

Loading...

Date Euros
2019 870,508,456.38
2018 862,168,795.00
2017 824,794,562.00
2016 780,161,032.00
2015 830,304,882.00
Download all data from 1995 to 2019

How does Greece rank in Sold Production of Medicaments, Containing Alkaloids or Derivatives Thereof, But Not Hormones or Antibiotics?

# 29 Countries Euros Last YoY 5‑years CAGR
1 #1
Germany
16,376,860,638.20 2019 +0.5 % +3.5 % View data
2 #2
Ireland
14,139,386,320.45 2019 +21.9 % -5.8 % View data
12 #12
Netherlands
935,716,741.45 2019 -4.9 % -4.6 % View data
13 #13
Greece
870,508,456.38 2019 +1.0 % +0.7 % View data
14 #14
Sweden
641,811,971.12 2019 +1,017.7 % +62.7 % View data
Compare all 29 countries

Go Top